Logo image of CAI

CARIS LIFE SCIENCES INC (CAI) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:CAI - US1421521071 - Common Stock

25 USD
-0.55 (-2.15%)
Last: 1/23/2026, 8:00:02 PM
25 USD
0 (0%)
After Hours: 1/23/2026, 8:00:02 PM
Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to CAI. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 38.65. This target is 54.59% above the current price.
  • CAI was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about CAI.
  • In the previous month the buy percentage consensus was at a similar level.
  • CAI was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
CAI Historical Analyst RatingsCAI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -50 -45 -40 -35 -30 -25 -20 -15 -10 -5 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 25.0030.3038.7638.6547.25 - 21.20% 55.04% 54.59% 89.00%
CAI Current Analyst RatingCAI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2025-12-22 Canaccord Genuity Maintains Hold -> Hold
2025-12-02 Canaccord Genuity Initiate Hold
2025-08-13 Guggenheim Maintains Buy -> Buy
2025-08-13 Evercore ISI Group Maintains Outperform -> Outperform
2025-08-13 Citigroup Maintains Buy -> Buy
2025-07-15 Evercore ISI Group Initiate Outperform
2025-07-14 TD Cowen Initiate Buy
2025-07-14 Guggenheim Initiate Buy
2025-07-14 Wolfe Research Initiate Outperform
2025-07-14 JP Morgan Initiate Overweight
2025-07-14 Citigroup Initiate Buy
2021-06-30 Keefe, Bruyette & Woods Downgrade Outperform -> Market Perform
2021-06-21 William Blair Downgrade Outperform -> Market Perform
2021-06-18 B. Riley Securities Downgrade Buy -> Neutral

CARIS LIFE SCIENCES INC / CAI FAQ

What is the price target for CAI stock?

13 analysts have analysed CAI and the average price target is 38.65 USD. This implies a price increase of 54.59% is expected in the next year compared to the current price of 25.


How do analysts rate CARIS LIFE SCIENCES INC (CAI)?

The consensus rating for CARIS LIFE SCIENCES INC (CAI) is 84.6154 / 100 . This indicates that analysts generally have a positive outlook on the stock.


What is the number of analysts for CAI stock?

The number of analysts covering CARIS LIFE SCIENCES INC (CAI) is 13.